拱东医疗
(605369)
| 流通市值：42.73亿 | | | 总市值：42.73亿 |
| 流通股本：2.20亿 | | | 总股本：2.20亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 845,084,320.3 | 556,922,772 | 264,475,758.74 | 1,115,209,505.65 |
| 营业收入 | 845,084,320.3 | 556,922,772 | 264,475,758.74 | 1,115,209,505.65 |
| 二、营业总成本 | 752,127,483.02 | 489,596,811.21 | 227,405,060.17 | 930,246,460.51 |
| 营业成本 | 590,427,890.11 | 382,565,407.85 | 178,781,250.8 | 749,489,891.31 |
| 税金及附加 | 8,935,216.86 | 5,087,421.29 | 2,817,315.45 | 12,939,542.16 |
| 销售费用 | 41,717,887.17 | 26,072,672.86 | 9,277,291.08 | 51,995,319.48 |
| 管理费用 | 76,162,010.4 | 52,255,089.82 | 26,285,023.23 | 89,214,250.51 |
| 研发费用 | 38,044,278.04 | 25,119,400.3 | 10,632,536.55 | 53,045,507.65 |
| 财务费用 | -3,159,799.56 | -1,503,180.91 | -388,356.94 | -26,438,050.6 |
| 其中:利息费用 | 5,507,067.04 | 3,660,308.98 | 2,025,895.87 | 2,870,555.81 |
| 其中:利息收入 | 13,590,208.15 | 6,688,140.06 | -2,667,290.8 | 23,627,152.19 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -557,249.18 | -528,936.68 | 1,574,728.67 | 4,071,171.28 |
| 加:投资收益 | -8,057,665 | -8,402,556.05 | -9,973,349.75 | 7,366,732.72 |
| 资产处置收益 | 181,313.34 | 225,096.57 | -150,100.84 | -20,506.38 |
| 资产减值损失(新) | -4,941,180.92 | -2,464,096.17 | -1,109,256.17 | -3,833,983.21 |
| 信用减值损失(新) | -3,350,567.51 | -2,574,440.19 | -761,850.23 | -4,524,512.8 |
| 其他收益 | 3,110,658.77 | 2,506,650.88 | 813,071.58 | 3,556,686.93 |
| 四、营业利润 | 79,342,146.78 | 56,087,679.15 | 27,463,941.83 | 191,578,633.68 |
| 加:营业外收入 | 9,177.67 | 5,650.7 | 0.57 | 332,368.6 |
| 减:营业外支出 | 256,035.79 | 238,212.9 | 523,857.56 | 3,175,850.44 |
| 五、利润总额 | 79,095,288.66 | 55,855,116.95 | 26,940,084.84 | 188,735,151.84 |
| 减:所得税费用 | 7,204,990.44 | 5,532,784.33 | -322,183.98 | 17,231,276.08 |
| 六、净利润 | 71,890,298.22 | 50,322,332.62 | 27,262,268.82 | 171,503,875.76 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 71,890,298.22 | 50,322,332.62 | 27,262,268.82 | 171,503,875.76 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 71,964,592.87 | 50,349,314.66 | 27,412,464.23 | 171,632,798.29 |
| 少数股东损益 | -74,294.65 | -26,982.04 | -150,195.41 | -128,922.53 |
| 扣除非经常损益后的净利润 | 80,126,777.39 | 59,756,341.35 | 34,743,984.95 | 168,149,512 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.33 | 0.23 | 0.17 | 1.09 |
| (二)稀释每股收益 | 0.33 | 0.23 | 0.17 | 1.09 |
| 八、其他综合收益 | -5,079,463.63 | -1,836,428.21 | -633,649.32 | 5,907,295.68 |
| 归属于母公司股东的其他综合收益 | -5,079,463.63 | -1,836,428.21 | -633,649.32 | 5,907,295.68 |
| 九、综合收益总额 | 66,810,834.59 | 48,485,904.41 | 26,628,619.5 | 177,411,171.44 |
| 归属于母公司股东的综合收益总额 | 66,885,129.24 | 48,512,886.45 | 26,778,814.91 | 177,540,093.97 |
| 归属于少数股东的综合收益总额 | -74,294.65 | -26,982.04 | -150,195.41 | -128,922.53 |
| 公告日期 | 2025-10-30 | 2025-08-26 | 2025-04-26 | 2025-04-22 |
| 审计意见(境内) | | | | 标准无保留意见 |